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Background
The progressive supranuclear palsy (PSP) constitutes the
second most common parkinsonian disorder after the idi-
opathic form of the disease with an incidence of 5.3 newly
diagnosed cases per 100,000 people annually and preva-
lence 1.39 per 100,000. Clinically, the disease presents
itself with not only motor symptoms but also dementia.
The aim of this study is to review and present all recent
data, specifically those related to the neuropathology and
biochemistry, of dementia in PSP.
Materials and methods
Recent advances in molecular and genetic research of PSP
are being reviewed. MRI and PET findings are analytically
described, while the utility of other exams, like EEG, in the
differential diagnosis between PSP and other dementias
evaluated.
Results
As depicted from the previous mentioned imaging meth-
ods and research, the reported significant learning deficits
in PSP are associated with disease-related lesions located
not only at subcortical (globus pallidus, mesencephalon,
corpus striatum), but also at cortical regions (prefrontal
and premotor cortex). A wide spectrum of symptoms is
correlated to the differential development of these lesions
from the neurofibrillary tangles within the cortex.
Conclusions
The progression of the condition to dementia is a charac-
teristic element of PSP, but does not occur in the same
manner in all patients. The type of the neurofibrillary tan-
gles and the range of the regions that they affect, differen-
tiate this condition from other neurodegenerative
disorders. Further research is required in relation to the
understanding of the neurotransmitter systems involved
in the memory and cognitive impairment of PSP, which
will be the cornerstone for the discovery and implementa-
tion of novel supportive care regimens.
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